EORTC Lung Cancer Group Spring Meeting
May 16 - May 18
Malaga, Spain
The EORTC Lung Cancer Group Spring Meeting will be held in Malaga, Spain on 16-18 May 2024 and is only open to individual or site staff members of the group.
Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the EORTC Lung Cancer Group, and you have not received the registration link, please contact events@eortc.org.
Venue: Rectorado de la Universidad de Málaga
AGENDA
Thursday 16 MAY – Spring meeting day 1Location: Rectorado de la Universidad de Málaga
|
||
| Time slot | Topic / Title of presentation | Speaker |
10h30 – 17h30 |
EORTC-LCG Y-ECI Meeting |
|
| 10h30 | Arrival and registration | |
| 11h00 – 13h15 | Y-ECI Meeting Part I | |
| 11h00 – 11h15 | Coffee & Introduction | Anne-Marie Dingemans |
| 11h15 – 11h45 | Rare thoracic cancers: what future research opportunities? | Nicolas Gerard |
| 11h45 – 12h15 | Older patients in clinical trials: advantages and challenges? | Lissandra Dal Lago |
| 12h15 – 13h15 |
Round-a-Table Mentorship sessions (1h in total)
|
Anne-Marie Dingemans, Jordi Remon, Lizza Hendriks Jose Manuel Trigo |
| 13h15 – 14h00 | Lunch break | |
| 14h00 – 18h00 | Y-ECI Meeting Part II | |
| 14h00 – 15h00 | Meet the Editor: tips & tricks for publication in high-impact journals | Diana Romero |
| 15h00 – 16h00 | Interaction with the industry (1 hour depending on attendance by industry) | Representatives of Amgen – Roche |
| 16h00 – 17h30 |
Discussion of 3 to 4 clinical trial proposals (1 to 1.5 hour in total; 5 min presentation + 15 min discussion): Radiotherapy in stage III thymic tumors according to IX TNM (Valeria Dionisi) Osimertinib after CRT guided by liquid biopsy (Laura Moliner) Phase 2 trial comparing lobectomy vs neoadjuvant SBRT followed by segmentectomy or atypical resection (Elena Prisciandaro / Niccolo Giaj-Levra) Phase II trial of first line cemiplimab+ axelopran, a peripherally active mu-opioid receptor antagonist – PAMORA, in opioid-exposed patients with PD-L1 ≥ 50% non-small cell lung cancer (NSCLC) (Alessio Cortellini) |
LCG Faculty: Anne-Marie Dingemans Jordi Remon Corinne Faivre-Finn Giannis Mountzios Jose Manuel Trigo LCG Board members |
| 18h00 – 20h00 | Board Meeting | LCG Board Members |
| 21h00 | Y-ECI Dinner – together with LCG board members and all speakers | |
Friday 17 MAY – Spring meeting day 2Location: Rectorado de la Universidad de Málaga
|
||
| Time slot | Topic / Title of presentation | Speaker |
11h00 – 13h00 |
EORTC-LCG Meeting Part I |
|
| 11h00 | Arrival and registration | |
| 11h30 – 11h40 | Introduction and welcome | Anne-Marie Dingemans |
| 11h40 – 12h00 | Performance, update on members, enrolling sites, queries | Anne-Marie Dingemans |
| 12h00 – 12h25 | Y-ECI update (including Elections) | Mariana Brandao |
| 12h25 – 13h00 |
Update on ongoing studies:
|
Natalia Rueda |
| 13h00 – 13h30 |
Protocols in (pre-) development: EORTC 37%4 Stage III Platform EORTC 37%3 LCNEC (COLINEAR) Platform EORTC 2346 Teliso Brain |
Mariana Brandao Anne-Marie Dingemans Lizza Hendriks |
| 13h30 – 15h30 | Lunch break | |
15h30 – 19h30 |
EORTC-LCG Symposium |
|
| 15h30 | Arrival and registration non-member delegates | |
| 15h30 – 17h00 | EORTC-LCG Symposium Part I | |
| 15h40 – 15h45 | Introduction |
Chair: Anne-Marie Dingemans ; Co-Chair : Jose Carlos Benitez |
| 15h45 – 16h00 | Resectable stage disease | Mariana Brandao |
| 16h00 – 16h15 | Challenges with the ICB in the peri-operative strategy | Jordi Remon |
| 16h15 – 16h30 | Challenges to implement perioperative strategy, surgical point of view | TBC |
| 16h30 – 16h45 | De-escalating treatment strategies with ICB | Benjamin Besse |
| 16h45 – 17h00 | Questions | All |
| 17h00 – 17h25 | Coffee Break | |
| 17h25 – 19h15 | EORTC-LCG Symposium Part II | |
| 17h25 – 17h30 | Introduction |
Chair: Anne-Marie Dingemans ; Co-Chair : Jose Carlos Benitez |
| 17h30 – 17h45 | Risk of Brain Mets | Lizza Hendriks |
| 17h45 – 18h00 | Quality of Life | Cecilia Pompili |
| 18h15 – 18h30 | Artificial intelligence in pathology | Jan von der Thusen |
| 18h30 – 18h45 | ADCs | Noemi Reguart |
| 18h45 – 19h00 | New trials with radiotherapy and ICB in the early-stage and stage III | Corinne Faivre-Finn |
| 19h00 – 19h15 | Round-a-table | All |
| 19h15 – 19h30 | Closing remarks | Anne-Marie Dingemans |
| 19h30 | Dinner for members only | |
Saturday 18 MAY – Spring meeting day 3Location: Rectorado de la Universidad de Málaga
|
||
| Time slot | Topic / Title of presentation | Speaker |
08h30 – 13h00 |
EORTC-LCG Meeting Part II |
|
| 09h00 | Arrival and registration | |
| 09h30 – 09h45 | Introduction and welcome |
Jordi Remon & Thierry Berghmans |
| 09h45 – 10h30 |
New proposals: LOWRIDER FAST-LUNG OSICANA ADD-ON (d)escalation in (neo)adjuvant treatment treatment of early-stage lung adenocarcinoma. CONCORDE Early versus delayed treatment with immunotherapy of relapsed cancers: 3 randomized trials (Innovative Heal Initiative call) |
Jonas Willmann Martin Igor Gomez-Randulfe Rodriguez Anne-Marie Dingemans / Jordi Remon Idris Bahce Jan von der Thüsen Corinne Faivre Finn Benjamin Besse |
| 10h30 – 11h00 | Coffee Break | |
| 11h00 – 11h40 |
Brainstorming on future studies Neoadjuvant/Peri-operative setting Uncommon EGFR mutations Stage III NSCLC NSCLC & Brain metastases |
Anne-Marie Dingemans Jordi Remon |
| 11h40 – 12h00 | Close Out | Anne-Marie Dingemans |
| 12h00 – 13h00 | Farewell lunch | |
Next events
EORTC Melanoma Group Autumn Meeting 2024
September 11 - September 12
Barcelona, Spain
CDDF-EORTC Workshop on Innovation and Access in Rare Cancers
September 23 - September 24
Amsterdam, NL (Hybrid Event)
EORTC Quality of Life Group Autumn Meeting 2024
September 26 - September 27
Innsbruck, Austria
EORTC Pathobiology Group Autumn Meeting 2024
October 2
Virtual Event
EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2024
October 9 - October 11
Lausanne, Switzerland
